{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T08:39:48Z","timestamp":1792571988455,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82102492"],"award-info":[{"award-number":["82102492"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472384"],"award-info":[{"award-number":["82472384"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-026-05673-0","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T06:54:55Z","timestamp":1788159295000},"page":"5171-5183","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["IGF1-IGF1R signaling in tumor-associated macrophages regulates extracellular matrix organization in BRAF inhibitor-targeted melanoma"],"prefix":"10.1007","volume":"481","author":[{"given":"Ya","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"issue":"1","key":"5673_CR1","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41392-021-00827-6","volume":"6","author":"W Guo","year":"2021","unstructured":"Guo W, Wang H, Li C (2021) Signal pathways of melanoma and targeted therapy. Signal Transduct Target Ther 6:424. https:\/\/doi.org\/10.1038\/s41392-021-00827-6","journal-title":"Signal Transduct Target Ther"},{"key":"5673_CR2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41572-025-00603-8","volume":"11","author":"A Tasdogan","year":"2025","unstructured":"Tasdogan A, Sullivan RJ, Katalinic A et al (2025) Cutaneous melanoma. Nat Rev Dis Primers 11:23. https:\/\/doi.org\/10.1038\/s41572-025-00603-8","journal-title":"Nat Rev Dis Primers"},{"key":"5673_CR3","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41571-022-00620-6","volume":"19","author":"MJ Pittet","year":"2022","unstructured":"Pittet MJ, Michielin O, Migliorini D (2022) Clinical relevance of tumour-associated macrophages. Nat Rev Clin Oncol 19:402\u2013421. https:\/\/doi.org\/10.1038\/s41571-022-00620-6","journal-title":"Nat Rev Clin Oncol"},{"key":"5673_CR4","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/ni.3710","volume":"18","author":"V Piccolo","year":"2017","unstructured":"Piccolo V, Curina A, Genua M et al (2017) Opposing macrophage polarization programs show extensive epigenomic and transcriptional cross-talk. Nat Immunol 18:530\u2013540. https:\/\/doi.org\/10.1038\/ni.3710","journal-title":"Nat Immunol"},{"key":"5673_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101611","volume":"5","author":"J Vasilevska","year":"2024","unstructured":"Vasilevska J, Cheng PF, Lehmann J et al (2024) Monitoring melanoma patients on treatment reveals a distinct macrophage population driving targeted therapy resistance. Cell Rep Med 5:101611. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101611","journal-title":"Cell Rep Med"},{"key":"5673_CR6","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ado8366","volume":"10","author":"N Wu","year":"2024","unstructured":"Wu N, Li J, Li L et al (2024) MerTK+ macrophages promote melanoma progression and immunotherapy resistance through AhR-ALKAL1 activation. Sci Adv 10:eado8366. https:\/\/doi.org\/10.1126\/sciadv.ado8366","journal-title":"Sci Adv"},{"key":"5673_CR7","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12943-023-01776-2","volume":"22","author":"Z Yuan","year":"2023","unstructured":"Yuan Z (2023) Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments. Mol Cancer 22:112. https:\/\/doi.org\/10.1186\/s12943-023-01776-2","journal-title":"Mol Cancer"},{"key":"5673_CR8","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1084\/jem.20151473","volume":"213","author":"R Afik","year":"2016","unstructured":"Afik R, Zigmond E, Vugman M et al (2016) Tumor macrophages are pivotal constructors of tumor collagenous matrix. J Exp Med 213:2315\u20132331. https:\/\/doi.org\/10.1084\/jem.20151473","journal-title":"J Exp Med"},{"key":"5673_CR9","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12943-024-02112-9","volume":"23","author":"X Chu","year":"2024","unstructured":"Chu X, Tian Y, Lv C (2024) Decoding the spatiotemporal heterogeneity of tumor-associated macrophages. Mol Cancer 23:198. https:\/\/doi.org\/10.1186\/s12943-024-02112-9","journal-title":"Mol Cancer"},{"key":"5673_CR10","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12967-023-04810-3","volume":"22","author":"J Xiong","year":"2024","unstructured":"Xiong J, Xiao R, Zhao J et al (2024) Matrix stiffness affects tumor-associated macrophage functional polarization and its potential in tumor therapy. J Transl Med 22:85. https:\/\/doi.org\/10.1186\/s12967-023-04810-3","journal-title":"J Transl Med"},{"key":"5673_CR11","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/JME-14-0215","volume":"54","author":"LA Bach","year":"2015","unstructured":"Bach LA (2015) Endothelial cells and the IGF system. J Mol Endocrinol 54:R1\u2013R13. https:\/\/doi.org\/10.1530\/JME-14-0215","journal-title":"J Mol Endocrinol"},{"key":"5673_CR12","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1038\/s41388-022-02376-w","volume":"41","author":"E Alfaro-Arnedo","year":"2022","unstructured":"Alfaro-Arnedo E, L\u00f3pez IP, Pi\u00f1eiro-Hermida S et al (2022) IGF1R acts as a cancer-promoting factor in the tumor microenvironment facilitating lung metastasis implantation and progression. Oncogene 41:3625\u20133639. https:\/\/doi.org\/10.1038\/s41388-022-02376-w","journal-title":"Oncogene"},{"key":"5673_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2020.111003","volume":"518","author":"H Werner","year":"2020","unstructured":"Werner H, Laron Z (2020) Role of the GH-IGF1 system in progression of cancer. Mol Cell Endocrinol 518:111003. https:\/\/doi.org\/10.1016\/j.mce.2020.111003","journal-title":"Mol Cell Endocrinol"},{"key":"5673_CR14","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.jid.2023.07.016","volume":"144","author":"C Castillo-Ferrer","year":"2024","unstructured":"Castillo-Ferrer C, Marguet T, Vanwonterghem L et al (2024) Serum IGF1 Is a Prognostic Marker for Resistance to Targeted Therapies and a Predictive Marker for Anti-IGF1 Receptor Therapy in Melanoma. J Invest Dermatol 144:422\u2013426e8. https:\/\/doi.org\/10.1016\/j.jid.2023.07.016","journal-title":"J Invest Dermatol"},{"key":"5673_CR15","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.jid.2021.07.162","volume":"142","author":"G Xu","year":"2022","unstructured":"Xu G, Luo Y, Wu W et al (2022) The Evolution of Acquired Resistance to BRAFV600E kinase inhibitor Is Sustained by IGF1-Driven Tumor Vascular Remodeling. J Invest Dermatol 142:445\u2013458. https:\/\/doi.org\/10.1016\/j.jid.2021.07.162","journal-title":"J Invest Dermatol"},{"key":"5673_CR16","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.celrep.2017.03.046","volume":"19","author":"O Spadaro","year":"2017","unstructured":"Spadaro O, Camell CD, Bosurgi L et al (2017) IGF1 Shapes Macrophage Activation in Response to Immunometabolic Challenge. Cell Rep 19:225\u2013234. https:\/\/doi.org\/10.1016\/j.celrep.2017.03.046","journal-title":"Cell Rep"},{"key":"5673_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26146778","volume":"26","author":"H Sikorski","year":"2025","unstructured":"Sikorski H, \u017bmijewski MA, Piotrowska A (2025) Tumor microenvironment in melanoma\u2014characteristic and clinical implications. Int J Mol Sci 26:6778. https:\/\/doi.org\/10.3390\/ijms26146778","journal-title":"Int J Mol Sci"},{"key":"5673_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.25958\/ecu.00009741","volume":"13","author":"LP Tangella","year":"2013","unstructured":"Tangella LP (2013) Resistance mechanisms to targeted therapy in BRAF-mutant melanoma - A mini review. ECU J Undergrad Res 13:1\u201312. https:\/\/doi.org\/10.25958\/ecu.00009741","journal-title":"ECU J Undergrad Res"},{"key":"5673_CR19","doi-asserted-by":"publisher","first-page":"13972","DOI":"10.1073\/pnas.1921224117","volume":"117","author":"S Bugide","year":"2020","unstructured":"Bugide S, Gupta R, Wang B et al (2020) Loss of HAT1 expression confers BRAFV600E inhibitor resistance to melanoma cells by activating MAPK signaling via IGF1R. Proc Natl Acad Sci U S A 117:13972\u201313981. https:\/\/doi.org\/10.1073\/pnas.1921224117","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5673_CR20","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.ccr.2010.10.020","volume":"18","author":"J Villanueva","year":"2010","unstructured":"Villanueva J, Vultur A, Lee JT et al (2010) Acquired Resistance to BRAF Inhibitors Mediated by a RAF Kinase Switch in Melanoma Can Be Overcome by Cotargeting MEK and IGF-1R\/PI3K. Cancer Cell 18:683\u2013695. https:\/\/doi.org\/10.1016\/j.ccr.2010.10.020","journal-title":"Cancer Cell"},{"key":"5673_CR21","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.3389\/fimmu.2019.01330","volume":"10","author":"C Tsatsanis","year":"2019","unstructured":"Tsatsanis C, Ieronymaki E, Daskalaki E et al (2019) Insulin Signaling and Insulin Resistance Facilitate Trained Immunity in Macrophages Through Metabolic and Epigenetic Changes. Front Immunol 10:1330. https:\/\/doi.org\/10.3389\/fimmu.2019.01330","journal-title":"Front Immunol"},{"key":"5673_CR22","doi-asserted-by":"publisher","first-page":"6521","DOI":"10.3390\/ijms22126521","volume":"22","author":"M Pellegrino","year":"2021","unstructured":"Pellegrino M, Secli V, D\u2019Amico S et al (2021) Manipulating the tumor immune microenvironment to improve cancer immunotherapy: IGF1R, a promising target. Int J Mol Sci 22:6521. https:\/\/doi.org\/10.3390\/ijms22126521","journal-title":"Int J Mol Sci"},{"key":"5673_CR23","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1210\/endrev\/bnab016","volume":"42","author":"LM Fettig","year":"2021","unstructured":"Fettig LM, Yee D (2021) Advances in insulin-like growth factor biology and -directed cancer therapeutics. Endocr Rev 42:821\u2013848. https:\/\/doi.org\/10.1210\/endrev\/bnab016","journal-title":"Endocr Rev"},{"key":"5673_CR24","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.bbi.2023.05.018","volume":"112","author":"DC Ivan","year":"2023","unstructured":"Ivan DC, Gheorghiu ML, Dobre M et al (2023) Insulin-like growth factor-1 receptor controls the function of CNS-resident macrophages and their contribution to neuroinflammation. Brain Behav Immun 112:245\u2013258. https:\/\/doi.org\/10.1016\/j.bbi.2023.05.018","journal-title":"Brain Behav Immun"},{"key":"5673_CR25","doi-asserted-by":"publisher","first-page":"4567","DOI":"10.1038\/s41388-022-02412-1","volume":"41","author":"S Diazzi","year":"2022","unstructured":"Diazzi S, Baeri A, Fassy J et al (2022) Blockade of the pro-fibrotic reaction mediated by the miR\u2010143\/\u2010145 cluster enhances the responses to targeted therapy in melanoma. Oncogene 41:4567\u20134578. https:\/\/doi.org\/10.1038\/s41388-022-02412-1","journal-title":"Oncogene"},{"key":"5673_CR26","doi-asserted-by":"publisher","first-page":"6039","DOI":"10.1158\/1078-0432.CCR-20-3452","volume":"27","author":"C Marusak","year":"2021","unstructured":"Marusak C, Thakur V, Li Y et al (2021) Targeting Extracellular Matrix Remodeling restores BRAF Inhibitor Sensitivity in BRAFi Resistant Melanoma. Clin Cancer Res 27:6039\u20136051. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-3452","journal-title":"Clin Cancer Res"},{"key":"5673_CR27","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s41035-022-00266-4","volume":"5","author":"C Yu","year":"2022","unstructured":"Yu C, Wang X, Zhang L et al (2022) Integrin-Src-YAP1 signaling mediates the melanoma acquired resistance to MAPK and PI3K\/mTOR dual targeted therapy. Mol Biomed 5:18. https:\/\/doi.org\/10.1186\/s41035-022-00266-4","journal-title":"Mol Biomed"},{"key":"5673_CR28","doi-asserted-by":"publisher","first-page":"5289","DOI":"10.1038\/s41388-021-02867-9","volume":"40","author":"I Berestjuk","year":"2021","unstructured":"Berestjuk I, Lecacheur M, Carminati A et al (2021) Targeting Discoidin Domain Receptors DDR1 and DDR2 overcomes matrix-mediated tumor cell adaptation and tolerance to BRAF\u2010targeted therapy in melanoma. Oncogene 40:5289\u20135302. https:\/\/doi.org\/10.1038\/s41388-021-02867-9","journal-title":"Oncogene"},{"key":"5673_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.116372","volume":"44","author":"P Biber","year":"2025","unstructured":"Biber P, Carminati A, Mohager W et al (2025) USP9X is a mechanosensitive deubiquitinase that controls tumor cell invasiveness and drug response through YAP stabilization. Cell Rep 44:116372. https:\/\/doi.org\/10.1016\/j.celrep.2025.116372","journal-title":"Cell Rep"},{"key":"5673_CR30","doi-asserted-by":"publisher","first-page":"612","DOI":"10.34172\/apb.2021.069","volume":"11","author":"AR Esimbekova","year":"2021","unstructured":"Esimbekova AR, Ziyaev A, Kadirova M et al (2021) Vemurafenib Induces Senescent Phenotype with Increased Adhesion in BRAF Mutant A375 but not in Wild Type BRAF SK-MEL-2 Melanoma Cells. Adv Pharm Bull 11:612\u2013620. https:\/\/doi.org\/10.34172\/apb.2021.069","journal-title":"Adv Pharm Bull"},{"issue":"1","key":"5673_CR31","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41392-025-02325-5","volume":"10","author":"J Xu","year":"2025","unstructured":"Xu J, Ding L, Mei J et al (2025) Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments. Signal Transduct Target Ther 10:268. https:\/\/doi.org\/10.1038\/s41392-025-02325-5","journal-title":"Signal Transduct Target Ther"},{"key":"5673_CR32","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1038\/s43018-024-00775-4","volume":"5","author":"KM Tharp","year":"2024","unstructured":"Tharp KM, Kersten K, Maller O et al (2024) Tumor-associated macrophages restrict CD8\u2009+\u2009T cell function through collagen deposition and metabolic reprogramming of the breast cancer microenvironment. Nat Cancer 5:1045\u20131062. https:\/\/doi.org\/10.1038\/s43018-024-00775-4","journal-title":"Nat Cancer"},{"issue":"1","key":"5673_CR33","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1038\/s41467-023-38093-5","volume":"14","author":"EH Puttock","year":"2023","unstructured":"Puttock EH, Tyler EJ, Manni M et al (2023) Extracellular matrix educates an immunoregulatory tumor macrophage phenotype found in ovarian cancer metastasis. Nat Commun 14:2514. https:\/\/doi.org\/10.1038\/s41467-023-38093-5","journal-title":"Nat Commun"},{"key":"5673_CR34","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2119168119","volume":"119","author":"MM LaRue","year":"2022","unstructured":"LaRue MM, Parker S, Puccini J et al (2022) Metabolic reprogramming of tumor-associated macrophages by collagen turnover promotes fibrosis in pancreatic cancer. Proc Natl Acad Sci U S A 119:e2119168119. https:\/\/doi.org\/10.1073\/pnas.2119168119","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05673-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05673-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05673-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T07:55:43Z","timestamp":1792569343000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05673-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":34,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["5673"],"URL":"https:\/\/doi.org\/10.1007\/s11010-026-05673-0","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]},"assertion":[{"value":"15 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal studies were approved by the Laboratory Animal Welfare and Ethics Committee of the Third Military Medical University and conducted in accordance with institutional guidelines and national regulations.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}